AZoNano.com reporter, Cameron Chai caught up with Jackie Fairley, CEO of Starpharma to ask her where Starpharma is heading with it’s leading nanotech products for pharmaceutical, life sciences and related applications.
In this insightful interview, Jackie Fairley discusses how the innovative nanoparticulate based dendrimer technology developed by Starpharma can be modified or customized to cater for specific applications.
Jackie also sheds light on the history of this innovative Australian-based company and how they have welcomed foreign investment to aid in their global growth. Growth to be driven by their Vivagel technology, licensed to SSL in the UK, a market leader in condom manufacture. For Starpharma, entry into this market has the potential to yield revenues in excess of AUD$100 million.
A Nanotech company to watch!
To hear this interview in full, please click here.